Five days of no anticoagulation or antiplatelet therapy and NovoSeven administration in a HeartWare HVAD patient.
Artif Organs
; 36(8): 751-3, 2012 Aug.
Article
em En
| MEDLINE
| ID: mdl-22607278
ABSTRACT
Postoperative bleeding is the most common complication following the implantation of ventricular assist devices. This is a case report of a HeartWare HVAD patient with intractable bleeding following chest tube insertion necessitating massive blood transfusion and multiple thoracotomies. Anticoagulation and antiplatelet therapy were discontinued and intravenous NovoSeven was administered as last resort. Bleeding ceased immediately and no pump-related issues were observed. However, thrombus formation in the right atrium and superior vena cava was detected.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Choque Cardiogênico
/
Inibidores da Agregação Plaquetária
/
Fator VIIa
/
Coração Auxiliar
/
Hemorragia Pós-Operatória
/
Anticoagulantes
Tipo de estudo:
Etiology_studies
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article